SB-202190
SB-202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinase with IC50 values of 50 nM and 100 nM for p38α and p38β respectively; also shows slightly weaker activity for BRD4 (Kd=3.4 μM).
| Trivial name | FHPI |
| Catalog Number | CSN12267 |
| Alternative Name(s) | FHPI |
| Research Area | Cancer |
| Molecular Formula | C20H14FN3O |
| CAS# | 152121-30-7 |
| Purity | ≥99% |
| SMILES | OC1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1 |
| Size | 25mg |
| Supplier Page | https://www.csnpharm.com/products/sb-202190.html |